Gram-Negative Rods and Coccobacilli

Gram-negative rods and coccobacilli are bacteria that do not retain crystal violet on Gram staining because their thin peptidoglycan layer sits beneath an outer membrane rich in lipopolysaccharide. The group spans the enteric Enterobacterales (such as Escherichia coli, Klebsiella, and Salmonella), the non-fermenting environmental opportunists (such as Pseudomonas aeruginosa and Acinetobacter), and the small fastidious coccobacilli (such as Haemophilus and Bordetella). They cause much of the world's burden of urinary, gastrointestinal, respiratory, and healthcare-associated infection.

Definition

Gram-negative rods and coccobacilli are rod- or short-rod-shaped Gram-negative bacteria characterized by an outer membrane containing lipopolysaccharide; medically they include the enteric Enterobacterales, the non-fermenting opportunists, and the fastidious respiratory coccobacilli.

Scope

The entry covers the structural feature that defines the group (the outer membrane and lipopolysaccharide), the laboratory distinctions used to sort it (lactose fermentation, oxidase reaction, shape), its major pathogenic strategies (endotoxin, secretion systems, multidrug resistance), and its broad clinical correlates. It is reference and educational material, not clinical guidance.

Core questions

• How does the Gram-negative outer membrane shape both the staining behaviour and the intrinsic drug resistance of this group?
• Which laboratory tests (lactose fermentation, oxidase, morphology) separate enteric from non-fermenting Gram-negative organisms?
• How do secretion systems and lipopolysaccharide contribute to disease?

Key concepts

• Outer membrane and lipopolysaccharide (endotoxin)
• Enterobacterales vs non-fermenters
• Lactose fermentation and oxidase testing
• Type III and other secretion systems
• ESKAPE pathogens and multidrug resistance
• Extended-spectrum and carbapenemase enzymes
• Coccobacilli (Haemophilus, Bordetella)

Mechanisms

The defining feature of Gram-negative organisms is the outer membrane, whose lipopolysaccharide acts as endotoxin and whose low permeability, combined with efflux pumps and beta-lactamases, underlies much of the group's intrinsic and acquired drug resistance (Blair et al., 2015; De Oliveira et al., 2020). Many of these pathogens use specialized secretion systems — notably the type III secretion system — to inject effector proteins that reprogramme host-cell signalling, as exemplified by Salmonella's manipulation of host membranes to enter and survive within cells (Deng et al., 2017; Haraga et al., 2008). In the laboratory, lactose fermentation and the oxidase reaction sort the enteric organisms from the non-fermenting opportunists, while colony and microscopic morphology distinguish the longer rods from the small coccobacilli.

Clinical relevance

Gram-negative rods and coccobacilli underlie much of the burden of urinary-tract, intra-abdominal, bloodstream, ventilator-associated, and other healthcare-associated infection, and several are flagged as priority drug-resistant pathogens. This entry describes the biology and classification that make the group clinically coherent as reference material; it is not a basis for diagnosis or for selecting therapy.

Epidemiology

Escherichia coli and Klebsiella pneumoniae are among the leading causes of bacterial infection and of resistance-associated death globally, and the non-fermenting opportunists Pseudomonas aeruginosa and Acinetobacter baumannii are central to the drug-resistant ESKAPE group that drives healthcare-associated infection (De Oliveira et al., 2020). Salmonella and other enteric organisms remain major causes of diarrhoeal and systemic disease worldwide (Haraga et al., 2008).

Evidence & guidelines

The ESKAPE resistance review (De Oliveira et al., 2020) and mechanistic reviews of secretion systems and resistance (Deng et al., 2017; Blair et al., 2015) frame the group's clinical and molecular biology, alongside standard medical-microbiology texts. The World Health Organization's priority-pathogen lists highlight several Gram-negative organisms; specific clinical management is covered in dedicated guidelines referenced elsewhere.

History

The Gram stain (1884) first split bacteria into Gram-positive and Gram-negative classes, and the enteric Gram-negative rods became central to early bacteriology through the study of typhoid, dysentery, and coliform organisms. The later recognition of endotoxin, of secretion systems, and of transferable resistance enzymes reframed the group around its outer membrane and its capacity to acquire multidrug resistance.

Key figures

• Samantha J. Pitt
• Wanyin Deng
• Samuel I. Miller
• Laura J. V. Piddock

Seminal works

• deoliveira-2020
• haraga-2008

Frequently asked questions

Why are Gram-negative bacteria often harder to treat than Gram-positive ones?

Their outer membrane is a permeability barrier that, together with efflux pumps and beta-lactamase enzymes, limits how many antibiotics can reach and act on the cell, giving the group substantial intrinsic and easily acquired resistance.

What separates enteric Gram-negative rods from non-fermenters in the laboratory?

Enteric Enterobacterales typically ferment glucose (and many ferment lactose) and are oxidase-negative, whereas non-fermenting opportunists such as Pseudomonas do not ferment sugars and are often oxidase-positive; these reactions are early steps in identification.